Single answer
Is 180 Life Sciences Corp (ATNFW) a buy or sell?
4starter turns market data into one clear verdict you can act on.
Create a free account to save tickers and track your signals.
Log in to turn on watchlist alerts.
Decision snapshot
Everything you need to act fast, in one glance.
What is the conclusion?
Right now our advanced algorithms say:
Do analysts agree?
We compare consensus targets with today's price.
No analyst target data available for this ticker.
Company snapshot
A quick overview of the business and its public profile.
180 Life Sciences Corp operates as a clinicalstage biotechnology company which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University the Hebrew University and Stanford University The company was founded by Marc Feldmann Lawrence J Steinman and Jonathan B Rothbard on September 7 2016 and is headquartered in Palo Alto CA
Website: http://www.180lifesciences.com
Rates and inflation backdrop
US inflation for January 2026 was 0.17%. Over the last 12 months, inflation is 2.83%. The 10-year yield is 4.04 and is down -0.110 over the last 30 days.
Inflation sensitivity
Debt ratio: 0.49. Cash flow to debt ratio: -0.04. Net profit margin: -5,476.94%. Inflation risk score: high (0.85/1).
Dividend history check
We cannot find any recorded dividends paid in our systems.
Trading liquidity
No, the average daily trading liquidity for 180 Life Sciences Corp is $184,362. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
10-year return check
We cannot find data for 180 Life Sciences Corp 10 years ago, but if you had invested on 2017-06-27 when the price was $0.200, you would have made a profit of $0.230 per share or 115.00%.
Why this answer
We combine price momentum, volatility, and trend signals to simplify the decision to one word.
Signal engine scans price, trend, and momentum indicators.
Targets and sentiment are checked against the live quote.
We keep the output simple: buy, sell, or hold.
Analyst consensus
How Wall Street targets compare to today's price.
No analyst target data available for this ticker.